Status:
COMPLETED
VisionRT-based Deep Inspiration Breath-hold (DIBH) Respiratory Motion Management Strategy, A Pilot Study for Thoracic and Abdominal Tumors
Lead Sponsor:
University of Texas Southwestern Medical Center
Collaborating Sponsors:
Vision RT Limited
Conditions:
Thoracic Cancer
Abdominal Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
A more recent competing technology for implementing the DIBH technique is real-time surface photogrammetry using the AlignRT system (Vision RT Ltd., London, UK). AlignRT system use non-ionization near...
Detailed Description
VRT-DIBH has already applied to left breast radiotherapy to spare lung and heart. Compared to ABC-DIBH, VRT-DIBH has several potential advantages: 1. VRT monitors patient (surface) position in additi...
Eligibility Criteria
Inclusion
- Patients must be willing and capable to provide informed consent to participate in the protocol.
- Patient with presumed pulmonary function capable of holding breath for at least 30 seconds - later to be confirmed.
- All men, as well as women of child-bearing potential must agree to use adequate contraception (hormonal or barrier method of birth control; abstinence) prior to study entry, and until study imaging is complete. Should a woman become pregnant or suspect she is pregnant while participating in this study, she should inform her treating physician immediately.
- 1 A female of child-bearing potential is any woman (regardless of sexual orientation, marital status, having undergone a tubal ligation, or remaining celibate by choice) who meets the following criteria:
- Has not undergone a hysterectomy or bilateral oophorectomy; or
- Has not been naturally postmenopausal for at least 12 consecutive months (i.e., has had menses at any time in the preceding 12 consecutive months).
- 2 Patients must be compliant to all required pretreatment evaluations
Exclusion
- Pregnant or lactating women, as treatment involves unforeseeable risks to the embryo or fetus
- Patients are not compliant to all required pretreatment evaluations
Key Trial Info
Start Date :
March 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 21 2023
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04686500
Start Date
March 1 2019
End Date
June 21 2023
Last Update
November 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UT Southwestern Medical Center
Dallas, Texas, United States, 75390